BLOODSTREAM INFECTION

Rapid Detection Can Lead to Better Outcomes


Bloodstream Infection Portfolio

 

For clinical labs, bloodstream infection testing encompasses a broad range of pathogens and is increasingly important for antimicrobial stewardship programs. From tracking antibiotic resistance markers in bacteria to diagnosing sepsis, a costly and life-threatening response to blood infection, patient care depends on getting reliable lab results quickly. Speed is so important because a sepsis patient’s mortality rate increases by 7.6% each hour that appropriate antibiotic treatment is delayed.1

 

Whether you’re focused on identifying causative pathogens or infection control, we have solutions to help.

 

Our portfolio of bloodstream infection diagnostics empowers clinical labs to identify pathogens and associated resistance markers, all with assay flexibility and scalability. These rapid blood culture tests can cut 24 to 48 hours off traditional test turnaround time, which has been shown to shorten hospital stays, lower costs, and improve outcomes by getting the right drug to the patient faster.2 In conjunction with antimicrobial stewardship programs, this approach also successfully reduces the use of unnecessary antibiotics.

 

Learn more about our bloodstream infection testing options:

 

 

 

 

 

Dive into the human body with this virtual reality experience to identify the pathogen ailing a very sick man. Once inside, it will be your job to find, analyze, and remove any pathogens that you discover and use the VERIGENE® system to test for a bloodstream infection.
 
*View this at 1440s or higher for the best experience.

 

 

 

Bloodstream Infection Testing Resources:

 

Investment Needed in Antimicrobial StewardshipBlog


Leading Pediatrics Hospital Finds Rapid Testing Reduces Unnecessary Use of AntibioticsBlog


The Pathologist: Labs Embrace Rapid Testing to Address Antibiotic ResistanceBlog


How a Community Hospital Saved $600,000 with Rapid DiagnosticsBlog


Impact of Antimicrobial Stewardship and Rapid Microarray Testing on Patients with Gram-Negative BacteremiaOutcomes Study from Cleveland Clinic


Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the VERIGENE Gram-Negative Blood Culture Multiplex Microarray-Based Molecular AssayJournal of Clinical Microbiology


Impact of a Rapid Blood Culture Assay for Gram-Positive Identification and Detection of Resistance Markers in a Pediatric HospitalArch Pathol Lab Med


Clinical Impact of Laboratory Implementation of Verigene BC-GN Microarray-Based Assay for Detection of Gram-Negative Bacteria in Positive Blood CulturesJournal of Clinical Microbiology

  1. Kumar A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
  2. Buchan BW, Ginocchio CC, Manii R, Cavagnolo R, Pancholi P, et al. (2013) Multiplex Identification of Gram-Positive Bacteria and Resistance Determinants Directly from Positive Blood Culture Broths: Evaluation of an Automated Microarray-Based Nucleic Acid Test. PLoS Med 10(7): e1001478. doi:10.1371/journal.pmed.1001478.

 

For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.